Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
John J. NicolsPresident & CEO932,4992.35%2015-03-05
Mr. Douglas T. SheehySVP, General Counsel & Sec.231,2050.58%2015-03-05
Dr. Patrick Y. Yang, PhDN/A229,5150.58%2014-11-18
James LalondeSVP, R&D163,9390.41%2015-03-05
Bernard KelleyDirector160,9490.41%2014-06-11
Thomas R. BaruchDirector138,4510.35%2014-06-11
Mr. Byron L. DorganN/A135,9510.34%2014-06-11
Mr. Dennis P. WolfN/A135,9510.34%2014-06-11
Mr. David D. O'TooleSVP & CFO110,6870.28%2013-09-04
Dr. David L. AntonSVP, BioIndustrials93,7770.24%2013-02-10

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Yang Patrick YDirector2014-11-18Buy20,000229,515$2.354791.49Link
Yang Patrick YDirector2014-11-17Buy20,000209,515$2.3446.892.31Link
CMEA VENTURES LIFE SCIENCES 20Director, 10% Owner2014-11-10Sell2,921,2250$2.376923.389.87Link
Yang Patrick YDirector2014-08-12Buy60,000189,515$2.22133.2102.7Link
NICOLS JOHN JPresident & CEO
(Click for the stocks that their CEOs have bought)
2013-03-08Buy27,000911,000$2.4265.385.95Link
NICOLS JOHN JPresident & CEO2013-03-07Buy54,000884,000$2.22119.9102.7Link
O'Toole David DSVP & CFO2013-03-04Buy10,000115,384$2.0220.2122.77Link
O'Toole David DSVP & CFO2012-11-12Buy5,00060,000$2.211104.55Link
O'Toole David DSVP & CFO2012-09-14Buy5,00055,000$2.7813.961.87Link
Sheehy Douglas T.SVP, General Counsel & Sec.2012-09-14Sell3,80069,200$2.7610.563.04Link
Anton David L.SVP, BioIndustrials2012-09-14Sell3,80070,200$2.7610.563.04Link
SHAW ALANPresident and CEO2011-12-16Sell53,846277,000$5.28284.3-14.77Link
SHAW ALANPresident and CEO2011-12-14Sell37,820330,846$5.27199.3-14.61Link
SHAW ALANPresident and CEO2011-07-07Sell15,000368,666$10.13152-55.58Link
SHAW ALANPresident and CEO2011-06-02Sell15,000368,666$10.39155.9-56.69Link
Lawson Robert JSVP and CFO2011-05-11Buy2,00044,000$9.519-52.63Link
SHAW ALANPresident and CEO2011-05-02Sell15,000268,666$10.44156.6-56.9Link
SHAW ALANPresident and CEO2011-04-01Sell15,000268,666$12.07181.1-62.72Link
SHAW ALANPresident and CEO2011-03-01Sell15,000218,666$10.65159.8-57.75Link
SHAW ALANPresident and CEO2011-02-11Sell15,000218,666$10.46156.9-56.98Link
BARUCH THOMAS RDirector2010-08-27Buy2,5002,742,658$7.5518.9-40.4Link
Pasternack Bruce ADirector2010-08-24Buy10,00010,000$7.7877.8-42.16Link
SHAW ALANPresident and CEO2010-08-10Buy2,00096,132$816-43.75Link
Sheehy Douglas T.SVP, Gen Counsel and Sec.2010-08-10Buy1,0001,000$7.998-43.68Link
Sarret Joseph J.CBO, President Pharmaceuticals2010-08-10Buy2,00015,333$7.9916-43.68Link
Lawson Robert JSVP and CFO2010-08-10Buy2,0002,000$816-43.75Link
Anton David L.SVP, Research and Development2010-08-10Buy2,0002,000$7.9916-43.68Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK